Prognostic correlations and response to treatment in advanced metastatic malignant melanoma

L. H. Einhorn, M. A. Burgess, C. Vallejos, G. P. Bodey, J. Gutterman, G. Mavligit, Evan M Hersh, J. K. Luce, E. Frei IIIrd, E. J. Freireich, J. A. Gottlieb

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

426 patients with disseminated melanoma were analyzed, all of whom were treated with chemotherapy. There was a high correlation with hepatic metastases and elevated lactic dehydrogenase levels. Although there were frequent false positive lactic dehydrogenase levels, normal lactic dehydrogenase levels were consistently associated with a normal liver. Central nervous system disease was a major cause of morbidity and mortality in metastatic melanoma. 11% of the patients in this study had evidence of central nervous system disease at onset. The only treatment that was proven to be effective in these patients was whole brain radiotherapy with concomitant dexamethasone administration. There were certain areas of anatomical involvement that correlated with an improved survival. These were patients that had pulmonary metastases only (median survival, 10 mth) and patients with disease limited to the skin and s.c. tissue (median survival 11 mth). The median survival for all patients was 4.7 mth. The response rate to a variety of treatment regimens with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamide was 18% (75 of 426) for all patients and 23% for evaluable patients only. There was an increased response to 5 (3,3 dimethyl 1 triazeno)imidiazole 4 carboxamide for nonvisceral involvement (28%), compared with visceral involvement (13%). The addition of 1,3 bis(2 chloroethyl) 1 nitrosourea appeared to have an increased response rate for pulmonary and other visceral involvement, compared with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamidalone. (14 references.)

Original languageEnglish (US)
Pages (from-to)1995-2004
Number of pages10
JournalCancer Research
Volume34
Issue number8
StatePublished - 1974
Externally publishedYes

Fingerprint

Melanoma
Oxidoreductases
Milk
Central Nervous System Diseases
Therapeutics
Survival
Neoplasm Metastasis
Tissue Survival
Carmustine
Lung
Dacarbazine
Liver
Dexamethasone
Radiotherapy
Morbidity
Drug Therapy
Skin
Mortality
Brain

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Einhorn, L. H., Burgess, M. A., Vallejos, C., Bodey, G. P., Gutterman, J., Mavligit, G., ... Gottlieb, J. A. (1974). Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Research, 34(8), 1995-2004.

Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. / Einhorn, L. H.; Burgess, M. A.; Vallejos, C.; Bodey, G. P.; Gutterman, J.; Mavligit, G.; Hersh, Evan M; Luce, J. K.; Frei IIIrd, E.; Freireich, E. J.; Gottlieb, J. A.

In: Cancer Research, Vol. 34, No. 8, 1974, p. 1995-2004.

Research output: Contribution to journalArticle

Einhorn, LH, Burgess, MA, Vallejos, C, Bodey, GP, Gutterman, J, Mavligit, G, Hersh, EM, Luce, JK, Frei IIIrd, E, Freireich, EJ & Gottlieb, JA 1974, 'Prognostic correlations and response to treatment in advanced metastatic malignant melanoma', Cancer Research, vol. 34, no. 8, pp. 1995-2004.
Einhorn LH, Burgess MA, Vallejos C, Bodey GP, Gutterman J, Mavligit G et al. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Research. 1974;34(8):1995-2004.
Einhorn, L. H. ; Burgess, M. A. ; Vallejos, C. ; Bodey, G. P. ; Gutterman, J. ; Mavligit, G. ; Hersh, Evan M ; Luce, J. K. ; Frei IIIrd, E. ; Freireich, E. J. ; Gottlieb, J. A. / Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. In: Cancer Research. 1974 ; Vol. 34, No. 8. pp. 1995-2004.
@article{73377b0e078b45ea9c575f9bac095a23,
title = "Prognostic correlations and response to treatment in advanced metastatic malignant melanoma",
abstract = "426 patients with disseminated melanoma were analyzed, all of whom were treated with chemotherapy. There was a high correlation with hepatic metastases and elevated lactic dehydrogenase levels. Although there were frequent false positive lactic dehydrogenase levels, normal lactic dehydrogenase levels were consistently associated with a normal liver. Central nervous system disease was a major cause of morbidity and mortality in metastatic melanoma. 11{\%} of the patients in this study had evidence of central nervous system disease at onset. The only treatment that was proven to be effective in these patients was whole brain radiotherapy with concomitant dexamethasone administration. There were certain areas of anatomical involvement that correlated with an improved survival. These were patients that had pulmonary metastases only (median survival, 10 mth) and patients with disease limited to the skin and s.c. tissue (median survival 11 mth). The median survival for all patients was 4.7 mth. The response rate to a variety of treatment regimens with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamide was 18{\%} (75 of 426) for all patients and 23{\%} for evaluable patients only. There was an increased response to 5 (3,3 dimethyl 1 triazeno)imidiazole 4 carboxamide for nonvisceral involvement (28{\%}), compared with visceral involvement (13{\%}). The addition of 1,3 bis(2 chloroethyl) 1 nitrosourea appeared to have an increased response rate for pulmonary and other visceral involvement, compared with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamidalone. (14 references.)",
author = "Einhorn, {L. H.} and Burgess, {M. A.} and C. Vallejos and Bodey, {G. P.} and J. Gutterman and G. Mavligit and Hersh, {Evan M} and Luce, {J. K.} and {Frei IIIrd}, E. and Freireich, {E. J.} and Gottlieb, {J. A.}",
year = "1974",
language = "English (US)",
volume = "34",
pages = "1995--2004",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Prognostic correlations and response to treatment in advanced metastatic malignant melanoma

AU - Einhorn, L. H.

AU - Burgess, M. A.

AU - Vallejos, C.

AU - Bodey, G. P.

AU - Gutterman, J.

AU - Mavligit, G.

AU - Hersh, Evan M

AU - Luce, J. K.

AU - Frei IIIrd, E.

AU - Freireich, E. J.

AU - Gottlieb, J. A.

PY - 1974

Y1 - 1974

N2 - 426 patients with disseminated melanoma were analyzed, all of whom were treated with chemotherapy. There was a high correlation with hepatic metastases and elevated lactic dehydrogenase levels. Although there were frequent false positive lactic dehydrogenase levels, normal lactic dehydrogenase levels were consistently associated with a normal liver. Central nervous system disease was a major cause of morbidity and mortality in metastatic melanoma. 11% of the patients in this study had evidence of central nervous system disease at onset. The only treatment that was proven to be effective in these patients was whole brain radiotherapy with concomitant dexamethasone administration. There were certain areas of anatomical involvement that correlated with an improved survival. These were patients that had pulmonary metastases only (median survival, 10 mth) and patients with disease limited to the skin and s.c. tissue (median survival 11 mth). The median survival for all patients was 4.7 mth. The response rate to a variety of treatment regimens with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamide was 18% (75 of 426) for all patients and 23% for evaluable patients only. There was an increased response to 5 (3,3 dimethyl 1 triazeno)imidiazole 4 carboxamide for nonvisceral involvement (28%), compared with visceral involvement (13%). The addition of 1,3 bis(2 chloroethyl) 1 nitrosourea appeared to have an increased response rate for pulmonary and other visceral involvement, compared with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamidalone. (14 references.)

AB - 426 patients with disseminated melanoma were analyzed, all of whom were treated with chemotherapy. There was a high correlation with hepatic metastases and elevated lactic dehydrogenase levels. Although there were frequent false positive lactic dehydrogenase levels, normal lactic dehydrogenase levels were consistently associated with a normal liver. Central nervous system disease was a major cause of morbidity and mortality in metastatic melanoma. 11% of the patients in this study had evidence of central nervous system disease at onset. The only treatment that was proven to be effective in these patients was whole brain radiotherapy with concomitant dexamethasone administration. There were certain areas of anatomical involvement that correlated with an improved survival. These were patients that had pulmonary metastases only (median survival, 10 mth) and patients with disease limited to the skin and s.c. tissue (median survival 11 mth). The median survival for all patients was 4.7 mth. The response rate to a variety of treatment regimens with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamide was 18% (75 of 426) for all patients and 23% for evaluable patients only. There was an increased response to 5 (3,3 dimethyl 1 triazeno)imidiazole 4 carboxamide for nonvisceral involvement (28%), compared with visceral involvement (13%). The addition of 1,3 bis(2 chloroethyl) 1 nitrosourea appeared to have an increased response rate for pulmonary and other visceral involvement, compared with 5 (3,3 dimethyl 1 triazeno)imidazole 4 carboxamidalone. (14 references.)

UR - http://www.scopus.com/inward/record.url?scp=0016186530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016186530&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 1995

EP - 2004

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 8

ER -